Reaction Details Report a problem with these data
Target
Galectin-3
Ligand
BDBM120773
Substrate
n/a
Meas. Tech.
Fluorescence Polarization-Based Assay
Kd
210±n/a nM
Citation
 Leffler, H; Nilsson, UJ; Von Wachenfeldt, H Galactoside inhibitors of galectins US Patent  US8703720 Publication Date 4/22/2014 
Target
Name:
Galectin-3
Synonyms:
LEG3_HUMAN | LGALS3 | MAC2
Type:
Enzyme
Mol. Mass.:
26156.54
Organism:
Homo sapiens (Human)
Description:
P17931
Residue:
250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI
  
Inhibitor
Name:
BDBM120773
Synonyms:
US8703720, 17
Type:
Small organic molecule
Emp. Form.:
C28H30F2N6O5S
Mol. Mass.:
600.637
SMILES:
OCC1O[C@@H](S[C@@H]2CCCC(C2O)n2cc(nn2)-c2ccc(F)cc2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1ccc(F)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: